News

Explore the Future of Cell and Gene Therapy in London

Explore the Future of Cell and Gene Therapy in London

London Hosts Pioneers of Cell and Gene Therapy

London is gearing up to be the center of attention for the field of cell and gene therapy (CGT) as industry pioneers gather to discuss the future and advancements of this impactful medical area. The GenScript Biotech Global Forum is set to take place, marking a pivotal moment for professionals amid rapid developments in CGT, a field recognized for its potential to revolutionize treatment paradigms.

The Promise of Cell and Gene Therapy

As advancements propel CGT into a new era, the medical community is witnessing transformative breakthroughs that bridge laboratory innovations with real-world applications. From pioneering genome editing techniques to sophisticated cell therapy approaches, CGT embodies the cutting edge of medical science, fueled by increased funding and novel ideas.

Join the Discussion at the Global Forum

Scheduled for November 20, the forum will coincide with the esteemed Jefferies London Healthcare Conference. Under the banner of "THE NEXT ERA OF CGT IS HERE," attendees can look forward to rich discussions on translating scientific achievements into meaningful patient outcomes.

Keynote Speakers Leading the Charge

The event promises to be enlightening with keynote addresses from some of the leading minds in CGT:

Dr. Craig Mello, a distinguished Nobel Laureate, will share insights from his groundbreaking work in RNA interference (RNAi), reflecting on how foundational scientific principles evolve into tangible therapeutic strategies. His presentation titled "RNAi: A Molecular Spark in an Information Inferno" will delve into the implications of RNA-based medicines in the evolving landscape of CGT.

Dr. Miguel Forte, a pivotal figure in clinical development, will discuss global perspectives on the challenges and hopes of CGT in his talk, "Crossing the Desert: Challenges and Reasons to Believe in Cell and Gene Therapy." His expertise will highlight the pivotal regulatory pathways and manufacturing intricacies shaping this dynamic field.

Panel Discussions: Insights from Industry Leaders

Attendees can expect engaging panel sessions that focus on critical areas influencing the trajectory of cell and gene therapy.

1st Panel: Navigating the Future of Cell Therapy

As cell therapy develops, various platforms, including autologous and allogeneic models, face unique challenges. This panel will showcase leading experts discussing innovative developments in cell therapy, featuring:

  • Ying Huang, CEO, Legend Biotech
  • Paul Stoffels, Former CSO, Johnson & Johnson
  • Paula Río, Head of the Bone Marrow Aplasia Unit
  • Marcello Maresca, Senior Director, AstraZeneca
  • Jonathan Esensten, Senior Advisor, Multiply Labs

2nd Panel: Gene Therapy and mRNA Therapeutics

This session will explore how innovative therapies are overcoming barriers in delivery and safety, reaffirming the potential for transformative treatments.

  • Sergio Linares, Unit Head, Sanofi
  • Luigi Calzolai, Scientific Officer, European Commission
  • Anna Cereseto, Head of Lab, University of Trento
  • Robin Shattock, Chair in Infection and Immunity, Imperial College

3rd Panel: Tackling Manufacturing Challenges in CGT

The complexities of CGT production can hinder progress. This panel will provide insights into strategies for enhancing manufacturing processes.

  • Jin Yin, CTO, ProBio
  • John Maher, Scientific Founder, Leucid Bio
  • Marten Hansen, Head of Laboratory, Sanquin

4th Panel: Aligning Innovation with Investment

Exploring the intersection of innovation and investments in the CGT field will be fundamental to driving sustainable business models. Panelists will share their views on navigating risks and opportunities ahead.

  • Laura Stoppel, Partner at RA Capital Management
  • Hongbo Lu, Founder, NextBio Capital

Final Call for Registrations

This is a unique opportunity for those involved in CGT to learn from the best in the industry and connect with fellow professionals. Participants will enjoy engaging keynote speeches, insightful panel discussions, and invaluable networking opportunities. Be part of this essential gathering to shape the future of cell and gene therapy.

Date: Thursday, November 20
Location: 116 Pall Mall, London, UK

Secure your complimentary ticket to this prestigious event!

Frequently Asked Questions

What is the GenScript Biotech Global Forum?

The forum is a gathering for professionals in the cell and gene therapy field to discuss innovations and challenges.

Who are the keynote speakers?

Notable speakers include Nobel Laureate Dr. Craig Mello and Dr. Miguel Forte from ISCT.

When is the event taking place?

The event will occur on November 20, 2025.

How can I register?

Registration is available online, and complimentary tickets are limited to the first 20 registrants.

What topics will be covered at the forum?

Topics include advancements in cell therapy, gene therapy, manufacturing challenges, and investment strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

New Cancer Center to Transform Rural Florida Care

Updated Category News Views 5

If you think living in a rural area means settling for second best when it comes to healthcare, Tampa General Hospital's got news for you. A brand-new cancer center is sprouting up in Loxahatchee—aimed squarely at providing top-tier cancer care to Florida's Glades region, where communities often get the short end of the stick when it comes to healthcare access. And...

Continue Reading
Amazon OIL9 Drivers Join Teamsters, Demand Better Pay

Updated Category News Views 4

Amazon's OIL9 Facility Faces Union Uprising Never a dull moment with Amazon, is there? Just when you think you've seen it all in the labor struggle world, drivers at Amazon's OIL9 facility in Merrillville, Indiana, decide to join the Teamsters. These folks are not just making deliveries; they're laying down the battle lines, demanding Amazon acknowledge their union and...

Continue Reading
Violet PR's Big Wins Hint at Industry Strategies

Updated Category News Views 5

A Shining Night in Morristown Picture Violet PR's team on top of the world, right there in Morristown, getting the accolades every agency dreams of—five awards from PRSA-NJ. It's not just an ego trip, either. This is about setting a high bar in the world of strategic communications, and they're flaunting their ability to drive growth and innovation in the economic...

Continue Reading
Beta Bionics Class Action: Critical Investor Alert

Updated Category News Views 4

An Investor's Wake-Up Call: Beta Bionics Lawsuit Folks, if you've got skin in the game with Beta Bionics (NASDAQ: BBNX), there's a storm on the horizon. We're talking big legal guns out and aimed at Beta Bionics with that class action suit looming. If you sunk some serious dough between July 30, 2025, and February 24, 2026, it's time to shake up and assess your losses....

Continue Reading
HYXI Eyes European Growth with Product Matrix Launch

Updated Category News Views 4

Unveiling the Future: HYXI's Grand Showcase You know you're onto something big when nearly 60 industry insiders travel halfway across the globe to see what you've got cooking. That's exactly what went down at HYXI's Hangzhou headquarters on October 21, 2026. Under a snazzy theme, "See Where It Begins, Shape the Future," this European Partner Day was more than just a...

Continue Reading
NorthStar Anesthesia Focuses on ASC Partnerships

Updated Category News Views 2

NorthStar's Growing Partnerships Amid Operational Woes Anesthesia isn’t always the first thing you’d think of in big market-moving terms, but when it comes to keeping ambulatory surgery centers (ASCs) afloat, it might just be the critical stitch. ASCs are getting pinched from all sides—rising costs, staffing nightmares, and those unexpected surgical disruptions that...

Continue Reading
OwnATC Empowers Trainers to Expand Access to Care

Updated Category News Views 3

The Untapped Potential of Athletic Trainers In a hustle to get people's bodies moving and grooving right, we often overlook a crucial player: the Certified Athletic Trainer (CAT). These folks have been shelved in schools or sports arenas for far too long, especially when their expertise could be lighting up communities across the map. Enter OwnATC, shaking things up. A...

Continue Reading
Duni Group Faces Ups and Downs in Q3 2026

Updated Category News Views 2

Navigating Choppy Waters: Duni's Third Quarter 2026 Alright, folks, let's dive into the latest from Duni Group—a company feeling the pinch but pushing through with some resilience. The third quarter 2026 report has just landed, and while some numbers are headed up, plenty are a bit of a gut punch. This isn't a crisis, but it's no smooth sailing either. Let's cut through...

Continue Reading
Invisors Expands PayBill Suite for Staffing Efficiency

Updated Category News Views 4

Invisors Doubles Down on Workday Integration The winds of change are whispering in the Professional & Business Services sector as Invisors rolls out its enhanced PayBill Suite. This move isn't just another tick on some corporate checklist; it's a serious play to streamline the gnarly process of transitions that staffing firms face. Invisors is tying this suite tightly...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 0

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading

Top 5 Most Recently Viewed Articles

The Weather Company: Leading the Charge in Forecast Accuracy

Updated Category News Views 253

The Weather Company: A Global Leader in Forecast Accuracy The Weather Company is making significant strides in the realm of weather forecasting. Utilizing a powerful combination of artificial intelligence, innovative technology, and expert meteorologists, it has become nearly four times more likely to be recognized as the most accurate weather forecasting service. This...

Continue Reading
Exciting Developments at Red Cat Holdings: Stock Offering Success

Updated Category News Views 223

Red Cat Holdings Successfully Completes Stock Offering Red Cat Holdings, Inc. (Nasdaq: RCAT) has made headlines recently with the successful closing of its public offering of common stock. This significant event brings in gross proceeds of approximately $172.5 million, which reflects the company’s robust performance in the drone technology sector. This offering included...

Continue Reading
Market Resilience Amidst Inflation and Geopolitical Dynamics

Updated Category News Views 118

Market Reactions to Inflation Data Inflation remains a pressing concern for the U.S. economy, but investors on Wall Street find comfort in a wave of optimism. This optimism is fueled by emerging peace talks regarding Ukraine and a modified tariff strategy proposed by Trump, which is considered less stringent than earlier anticipated. Consumer Price Index and Influencing...

Continue Reading
United Airlines Earnings Forecasts: Analyst Ratings Insights

Updated Category News Views 167

United Airlines Prepares for Significant Earnings Release United Airlines Holdings, Inc. (NASDAQ: UAL) is set to announce its second quarter earnings shortly, with market participants eagerly anticipating the company's financial performance. After a long wait, investors are poised to learn whether the major carrier can continue its trend of growth and profitability, which...

Continue Reading
Top Consumer News You Need to Know This December

Updated Category News Views 158

Top Consumer News You Need to Know This December The month of December is a rich tapestry of consumer activity as brands ramp up their offerings for the holiday season. With countless press releases filling the news landscape, consumers and journalists can find valuable insights amidst this bustle. Here we round up some notable trends and announcements that define this...

Continue Reading